Location
United States, North America
Cheque size
$500K - $1M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
BioTech
About Investor
David Grayzel is a Partner at Atlas Venture, where he focuses on novel therapeutics and often works on companies nearing first-in-human clinical testing. A physician by training, he has co-founded and helped build multiple biotech companies through Atlas, including Arteaus Therapeutics and Annovation Biopharma, and has also served on the founding boards of Delinia and Cadent Therapeutics. Signal lists his investment range at Atlas as $500K to $5M.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.